The landscape of dementia care is experiencing a profound transformation, driven by a remarkable surge in the global dementia care products market. Industry experts project the market to reach a staggering valuation of USD 56.7 million by 2033, reflecting a substantial increase from USD 29.1 million in 2023. This growth, characterized by a robust Compound Annual Growth Rate (CAGR) of 6.9%, signals a significant evolution in disease management and highlights an intensified commitment to improving patient care.
The escalating prevalence of dementia worldwide has emphasized the urgent need for innovative solutions that enhance the quality of life for patients and their caregivers. The surge in the dementia care products market represents a collective effort to address this critical need, offering hope and support to millions of individuals affected by this condition.
Parentgiving, Inc. is at the forefront of this movement, dedicated to enhancing the quality of life for those living with Alzheimer’s and dementia. Our carefully curated selection of dementia care products is designed to empower both caregivers and individuals living with memory loss, providing innovative solutions to everyday challenges. From safety and security to comfort and cognitive stimulation, our range of products is thoughtfully crafted to support every aspect of dementia care.
“We believe that every individual living with dementia deserves the best possible care, and we are committed to providing the tools and resources necessary to make that happen,” said a spokesperson from Parentgiving, Inc. “Our products are more than just tools—they are part of a comprehensive approach to care that prioritizes dignity, comfort, and safety for both patients and caregivers.”
As the global dementia care products market continues its upward trajectory, Parentgiving, Inc. remains committed to leading the way in innovative, compassionate care solutions. Together, we can improve the lives of those affected by dementia, ensuring they receive the care and support they need.
Top Highlights from the FMI’s Analysis of the Dementia care products industry:
- North America’s dementia care products industry gained a notable size of 36.7% in 2022. The market growth can be credited to the surging work pressure and stress, which is contributing toward widespread dementia. Besides, neurological diseases like epilepsy, Parkinson’s disease, and stroke are pushing the market growth.
- Europe’s dementia care products industry acquired a market share of 31.3% in 2022. The surging prevalence of Alzheimer’s disease in the region is fueling market growth. The increasing cases of delirium, depression, thyroid problems, overuse of alcohol, and side effects from certain medications are enhancing regional growth.
- China is expanding at a quick pace of 9.2% CAGR from 2023 to 2033, whereas India is expected to register a CAGR of 8.8% over the same period.
- The United Kingdom’s dementia care products industry is projected to display a CAGR of 7.3% from 2023 to 2033.
- Based on product, the memory exercise and activity products segment attained a market share of 28.7% in 2022.
- Under the category of end user, the long-term care centers segment attained a prominent share of 58.7% in 2022.
Get Comprehensive Market Data: Download the Complete Dementia Care Products Market Report
Key Players in the Global Dementia Care Products Market:
Some of the players in the dementia care products market include Parentgiving, Inc., EasierLiving LLC, Find Memory Care, Healthcare products LLC, Best Alzheimer’s Products, NRS Healthcare, Buddi Ltd. Etc. There are a few projects in the pipeline for dementia care products. The leading manufacturers of dementia care products are focused to collaborate with the regional and local distributors to expand their market presence and upsurge their revenue from this system.
- In September 2021, Parentgiving Inc., the country’s premier retailer of caregiving products for the aging, announced the expansion of its Dry Direct incontinence line adding world-class Italian comfort, softness, and performance consumers expect from the leader in premium incontinence products.
- In June 2021, Biogen and Eisai, Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid-beta plaques in the brain.
Key Segments Covered in the Dementia Care Products Industry Survey:
By Product Type:
- Memory Exercise & Activity Products
- Daily Reminder Products
- Bathroom Safety Products
- Dining Aids
- Communication Products
- Personal Safety Products
- Other Product Types
By End User:
- Home Care Settings
- Long-term Care Centers
By Region:
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- Latin America
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube